Streptococcus pneumoniae Antibodies, IgG, Polysaccharide Vaccine (11 serotypes) (INACTIVE as of 02/18/14. Refer to 2008919)
Ordering Recommendation
Quantitative Multiplex Bead Assay
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Serum separator tube. Post-immunization specimen should be drawn 30 days after immunization and, if shipped separately, must be received within 60 days of pre-immunization specimen. 
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1.5 mL serum to an ARUP Standard Transport Tube. (Min: 0.25 mL) MARK SPECIMENS CLEARLY AS "PRE" OR "POST" SO SPECIMENS WILL BE SAVED AND TESTED SIMULTANEOUSLY. 
Storage/Transport Temperature
Refrigerated. "Pre" and "post" pneumococcal vaccine specimens can be submitted separately or together for testing. 
Unacceptable Conditions
Plasma or other body fluids. Contaminated, hemolyzed, or severely lipemic specimens. 
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles). 
Reference Interval
Interpretive Data
A post-immunization antibody concentration of 1.30 µg/mL or greater indicates adequate immune response. When comparing to pre-immunization concentrations that are 1.30 µg/mL or greater, a fourfold or greater increase in post-immunization concentration indicates adequate response; however, a high pre-immunization antibody concentration may preclude a fourfold increase.

Indication of immune system competence is demonstrated by an adequate immune response to at least 50 percent of the serotypes included in the vaccine challenge.

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Includes Serotypes 2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F

This test is designed to use both pre- and post-immunization specimens to assess immune responsiveness to pneumococcal vaccine. This test is not designed to determine protection to Streptococcus pneumoniae based on a single specimen.
CPT Code(s)
86317 X 11
Component Test Code*Component Chart NameLOINC
0050717Pneumo serotype 9N IgG (PNX)27392-0
0050721Pneumo serotype 8 IgG (PNX)27113-0
0050723Pneumo serotype 12F IgG (PNX)27374-8
2005780Pneumo serotype 2 IgG (PNX)40964-9
2005781Pneumo serotype 10A IgG (PNX)40967-2
2005782Pneumo serotype 11A IgG (PNX)40968-0
2005783Pneumo serotype 15B IgG (PNX)40973-0
2005784Pneumo serotype 17F IgG (PNX)40963-1
2005786Pneumo serotype 20 IgG (PNX)40965-6
2005787Pneumo serotype 22F IgG (PNX)40966-4
2005788Pneumo serotype 33F IgG (PNX)40969-8
2005789Pneumo Serotype Interpretation42771-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • Strep antibody vaccine response
  • Streptococcus pneumoniae vaccine